AC Immune S.A. ( ACIU) - Key Metrics
ACIU Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $0 | -$0.14 | -$0.16 | -$0.16 |
| 2025Q3 | $0.01 | -$0.16 | -$0.19 | -$0.19 |
| 2025Q2 | $0.01 | -$0.21 | -$0.16 | -$0.16 |
| 2025Q1 | $0.01 | -$0.19 | -$0.19 | -$0.19 |
| 2024Q4 | $0.01 | -$0.14 | $0.05 | $0.05 |
ACIU Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | -4.42 |
| 2025Q3 | ? | -3.59 |
| 2025Q2 | ? | -1.91 |
| 2025Q1 | ? | -2.18 |
| 2024Q4 | ? | -4.27 |
ACIU Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q4 | -6.57% | ? |
| 2025Q3 | -8.08% | ? |
| 2025Q2 | -9.86% | ? |
| 2025Q1 | -11.55% | ? |
| 2024Q4 | 2.17% | ? |
ACIU
Price: $2.31
52 week price:
Earnings Per Share: -0.84 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: Switzerland
Volume: 182100
Ebitda: -8.8 millionMarket Capitalization: 239.7 million